Structural Heart Procedures Market Size to Reach USD 28.02 Billion by 2034 at a 8.72% CAGR from 2026 to 2034
Structural heart procedures industry size is estimated at USD 13.20 billion in 2025 and forecasted to reach USD 28.02 billion in 2034 with a CAGR of 8.72%. Structural heart procedures involve minimally invasive and surgical treatments used to repair or replace damaged heart valves and correct structural heart defects.
Key Statistics:
- Market Size (2025): USD 13.20 Billion
- Market Size (2034): USD 28.02 Billion
- CAGR (2026-2034): 8.72%
- Dominating Region: North America
Report Highlights:
- The TAVR segment led the market in 2025, holding nearly 62.40% share, driven by the increasing preference for minimally invasive aortic valve replacement procedures.
- The hospitals segment accounted for the largest share in 2025, contributing approximately 68.70%, supported by advanced cardiac care infrastructure and availability of skilled specialists.
- The TMVR segment is projected to witness the fastest growth, registering a CAGR of around 13.20% during the forecast period due to the rising prevalence of mitral valve disorders.
- The tricuspid regurgitation segment is anticipated to grow at a CAGR of nearly 12.80% over the forecast period, driven by increasing awareness and diagnosis of untreated valve diseases.
- North America held a dominant position in 2025, capturing nearly 41.60% market share, supported by advanced healthcare systems and high adoption of structural heart treatments.
- Key companies include Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, Meril Life Sciences, and others.
What’s Included in Structural Heart Procedures Report?
The report presents a detailed overview of the market for structural heart procedures based on procedure, indication, and end user. It includes regional analysis, demand trends, treatment adoption patterns, and competitive landscape.
What are Driving Factors and Emerging Trends of Structural Heart Procedures Market?
According to our research, the market is growing owing to rising heart disease burden and increasing demand for minimally invasive treatment options. Several key drivers exist for the growth of the structural heart procedures sector. They include:
- Valve Disease Growth: Rising cases of aortic stenosis and mitral regurgitation are increasing treatment demand.
- Aging Population Expansion: Aging population is facilitating procedure volume growth.
- AI Integration Growth: Advanced algorithms are revolutionizing clinical care delivery.
This aligns with the rising focus on faster recovery, precision treatment, and advanced cardiac care.
Request a free sample copy or read the full market insights: Structural Heart Procedures Market Report
Which Key Segments are Driving Structural Heart Procedures Market?
By Procedure Analysis
TAVR segment held the largest market share due to strong demand for minimally invasive aortic valve replacement.
By Indication Analysis
Aortic stenosis segment dominated the market due to high prevalence among elderly patients.
By End User Analysis
Hospitals segment dominated the market due to advanced cardiac facilities and specialist availability.
Which is Dominating Region in Structural Heart Procedures Market?
North America: North America dominated the industry in 2025 due to strong healthcare spending and advanced cardiac treatment access.
Asia Pacific: Asia Pacific is expected to grow at the fastest rate due to rising cardiovascular disease burden in China and India.
Where is Structural Heart Procedures Market Headed?
According to analysis, the market is moving toward steady expansion supported by device innovation, AI-enabled imaging, and wider adoption of minimally invasive cardiac procedures.
What Structural Heart Procedures Market Report Reveals?
- What is the global market size, growth trend, and CAGR for structural heart procedures through 2034?
- What are the factors driving the market growth?
- Which companies make up the top players, and how do they compare in competitive positioning?
- How are companies reducing device costs to improve adoption in emerging markets?
- How is AI-based imaging changing competition in the global structural heart procedures industry?
- What are the trends in the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
- Where do new opportunities arise in the structural heart procedures market?
Who are Major Structural Heart Procedures Market Contributors?
According to our study, a few firms are leading in the global market. The following are some of the major market contributors:
- Abbott Laboratories
- Artivion
- Boston Scientific
- Edwards Lifesciences
- JenaValve Technology
- Johnson & Johnson MedTech
- LivaNova
- Medtronic
- Meril Life Sciences
- MicroPort Scientific
- Peijia Medical
- Venus Medtech
Market Segments Covered
By Procedure Outlook (Revenue, USD Billion, 2021-2034)
- TAVR
- TMVR
- LAAC
- Others
By Indication Outlook (Revenue, USD Billion, 2021-2034)
- Aortic Stenosis
- Mitral Regurgitation
- Congenital Heart Defects
- Atrial Fibrillation
- Tricuspid Regurgitation
By End User Outlook (Revenue, USD Billion, 2021-2034)
- Hospitals
- Specialized Cardiac Centers
- Others
By Regional Outlook (Revenue, USD Billion, 2021-2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Netherland
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Australia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Rest of Middle East & Africa
